John W. Smither, Chief Financial Officer at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 375 shares at $35.61 ($13K) on 2014-09-22, disclosed to the SEC on 2014-09-22.
Scheduled sale ($13k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GNLX | SELL | 2023-09-14 | $19K | — | Filing → |
| ARQT | SELL | 2021-03-11 | $58K | — | Filing → |
| ARQT | SELL | 2021-03-03 | $26K | — | Filing → |